Try our Advanced Search for more refined results

October 31, 2017

ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED et al v. PRINSTON PHARMACEUTICAL INC. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 15, 2021

    Allergan Cuts Deal With Generic Cos. Over Depression Drug

    A New Jersey federal judge has signed off on a deal between Allergan and two generic-drug makers to resolve patent infringement suits it launched to prevent a generic version of its depression drug Fetzima from hitting the market.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login